{"pmid":32387155,"title":"Digital Ischemia in COVID-19 Patients: Case Report.","text":["Digital Ischemia in COVID-19 Patients: Case Report.","As coronavirus 2019 continues to cause an immense burden on the global health care systems, it is crucial to understand the breadth of this disease process. Recent reports identified hypercoagulability in a subset of critically ill patients and extremity ischemia in an even smaller cohort. Because abnormal coagulation parameters and extremity ischemia have been shown to correlate with poor disease prognosis, understanding how to treat these patients is crucial. To describe the identification and management of this phenomenon better, we present 2 cases of critically ill patients with coronavirus 2019 who developed fingertip ischemia while in the intensive care unit.","J Hand Surg Am","Schultz, Kathryn","Wolf, Jennifer Moriatis","32387155"],"abstract":["As coronavirus 2019 continues to cause an immense burden on the global health care systems, it is crucial to understand the breadth of this disease process. Recent reports identified hypercoagulability in a subset of critically ill patients and extremity ischemia in an even smaller cohort. Because abnormal coagulation parameters and extremity ischemia have been shown to correlate with poor disease prognosis, understanding how to treat these patients is crucial. To describe the identification and management of this phenomenon better, we present 2 cases of critically ill patients with coronavirus 2019 who developed fingertip ischemia while in the intensive care unit."],"journal":"J Hand Surg Am","authors":["Schultz, Kathryn","Wolf, Jennifer Moriatis"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387155","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jhsa.2020.04.024","keywords":["covid-19","critical care","digital ischemia","hand","hypercoagulability"],"topics":["Case Report"],"weight":1,"_version_":1666428892702834692,"score":9.490897,"similar":[{"pmid":32447121,"title":"Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.","text":["Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.","Acute thromboembolic events appear to be frequent in patients with SARS-CoV-2 infection. We report a case of an intubated patient, who developed a threatening lower limb ischemia. Intra-arterial fibrinolysis and intravenous heparin infusion did not lead to complete recanalization of the tibial arteries, which were successfully treated by surgical embolectomy.","Int J Infect Dis","Andrea, Vacirca","Gianluca, Faggioli","Rodolfo, Pini","Paolo, Teutonico","Alessandro, Pilato","Mauro, Gargiulo","32447121"],"abstract":["Acute thromboembolic events appear to be frequent in patients with SARS-CoV-2 infection. We report a case of an intubated patient, who developed a threatening lower limb ischemia. Intra-arterial fibrinolysis and intravenous heparin infusion did not lead to complete recanalization of the tibial arteries, which were successfully treated by surgical embolectomy."],"journal":"Int J Infect Dis","authors":["Andrea, Vacirca","Gianluca, Faggioli","Rodolfo, Pini","Paolo, Teutonico","Alessandro, Pilato","Mauro, Gargiulo"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447121","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ijid.2020.05.060","keywords":["acute limb ischemia","covid-19","sars-cov-2 infection","thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1667698385959780352,"score":209.80243},{"pmid":32378743,"title":"Acro-ischemia in hospitalized COVID-19 patients.","text":["Acro-ischemia in hospitalized COVID-19 patients.","Dermatological manifestations of the Coronavirus Disease 2019 (COVID-19) may include unspecific macular erythematous rash, urticarial lesions and chickenpox-like vesicles(1,2) . Acroischemic lesions have been described in two different types of COVID-19 patients. Firstly, critically ill patients with severe limb ischemia and secondly, paucisymptomatic young patients with chilblain-like lesions(3) . The etiopathogenesis and clinical implications of these lesions remains unclear.","J Eur Acad Dermatol Venereol","Suarez-Valle, A","Fernandez-Nieto, D","Diaz-Guimaraens, B","Dominguez-Santas, M","Carretero, I","Perez-Garcia, B","32378743"],"abstract":["Dermatological manifestations of the Coronavirus Disease 2019 (COVID-19) may include unspecific macular erythematous rash, urticarial lesions and chickenpox-like vesicles(1,2) . Acroischemic lesions have been described in two different types of COVID-19 patients. Firstly, critically ill patients with severe limb ischemia and secondly, paucisymptomatic young patients with chilblain-like lesions(3) . The etiopathogenesis and clinical implications of these lesions remains unclear."],"journal":"J Eur Acad Dermatol Venereol","authors":["Suarez-Valle, A","Fernandez-Nieto, D","Diaz-Guimaraens, B","Dominguez-Santas, M","Carretero, I","Perez-Garcia, B"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32378743","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jdv.16592","keywords":["covid 19","sars","acro-ischemia","acrocyanosis","coronavirus","virus"],"topics":["Diagnosis"],"weight":1,"_version_":1666597097350103041,"score":208.40509},{"pmid":32447934,"title":"[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","text":["[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","Objective: To investigate the clinical and coagulation characteristics in patients with critical Coronavirus disease 2019 (COVID-19) and acro-ischemia. Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in an intensive care unit (ICU) in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. Three patients were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time was prolonged in 4 patients. D-dimer and FDP levels progressively elevated consistent with COVID-2019 exacerbation. Four patients were diagnosed with disseminated intravascular coagulation (DIC) . Low molecular weight heparin (LMWH) was administrated in 6 patients, which reduced D-dimer and FDP rather than improved clinical symptoms. Five patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: Coagulation parameters should be monitored closely in critical COVID-2019 patients. The timing and protocol of anticoagulation therapy are still under investigation based on more clinical data.","Zhonghua Xue Ye Xue Za Zhi","Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S","32447934"],"abstract":["Objective: To investigate the clinical and coagulation characteristics in patients with critical Coronavirus disease 2019 (COVID-19) and acro-ischemia. Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in an intensive care unit (ICU) in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. Three patients were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time was prolonged in 4 patients. D-dimer and FDP levels progressively elevated consistent with COVID-2019 exacerbation. Four patients were diagnosed with disseminated intravascular coagulation (DIC) . Low molecular weight heparin (LMWH) was administrated in 6 patients, which reduced D-dimer and FDP rather than improved clinical symptoms. Five patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: Coagulation parameters should be monitored closely in critical COVID-2019 patients. The timing and protocol of anticoagulation therapy are still under investigation based on more clinical data."],"journal":"Zhonghua Xue Ye Xue Za Zhi","authors":["Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32447934","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3760/cma.j.issn.0253-2727.2020.008","keywords":["anticoagulation therapy","covid-2019","critical","hypercoagulation status"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Heparin, Low-Molecular-Weight"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213980180480,"score":199.70645},{"pmid":32220276,"title":"[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","text":["[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].","Objective: To investigate the clinical and coagulation characteristics of the critical Coronavirus disease 2019 (COVID-19) patients with acro-ischemia in the intensive care unit (ICU). Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in a single center in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. 3 of them were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time (PT) were prolonged in 4 patients. D-dimer and FDP levels increased progressively when COVID-2019 exacerbated, and 4 patients were diagnosed with definite disseminated intravascular coagulation (DIC). 6 patients received low molecular weight heparin (LMWH) treatment, after which their D-dimer and FDP decreased, but there was no significant improvement in clinical symptoms. 5 patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: The existence of hypercoagulation status in critical COVID-2019 patients should be monitored closely, and anticoagulation therapy can be considered in selected patients. More clinical data is needed to investigate the role of anticoagulation in COVID-2019 treatment.","Zhonghua Xue Ye Xue Za Zhi","Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S","32220276"],"abstract":["Objective: To investigate the clinical and coagulation characteristics of the critical Coronavirus disease 2019 (COVID-19) patients with acro-ischemia in the intensive care unit (ICU). Methods: The retrospective study included 7 critical COVID-19 patients with acro-ischemia in a single center in Wuhan, from Feb 4 to Feb 15, 2020. The clinical and laboratory data before and during the ICU stay were analyzed. Results: The median age of 7 patients was 59 years and 4 of them were men. 3 of them were associated with underlying comorbidities. Fever, cough, dyspnea and diarrhea were common clinical symptoms. All patients had acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene. D-dimer, fibrinogen and fibrinogen degradation product (FDP) were significantly elevated in most patients. Prothrombin time (PT) were prolonged in 4 patients. D-dimer and FDP levels increased progressively when COVID-2019 exacerbated, and 4 patients were diagnosed with definite disseminated intravascular coagulation (DIC). 6 patients received low molecular weight heparin (LMWH) treatment, after which their D-dimer and FDP decreased, but there was no significant improvement in clinical symptoms. 5 patients died finally and the median time from acro-ischemia to death was 12 days. Conclusions: The existence of hypercoagulation status in critical COVID-2019 patients should be monitored closely, and anticoagulation therapy can be considered in selected patients. More clinical data is needed to investigate the role of anticoagulation in COVID-2019 treatment."],"journal":"Zhonghua Xue Ye Xue Za Zhi","authors":["Zhang, Y","Cao, W","Xiao, M","Li, Y J","Yang, Y","Zhao, J","Zhou, X","Jiang, W","Zhao, Y Q","Zhang, S Y","Li, T S"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220276","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3760/cma.j.issn.0253-2727.2020.0006","keywords":["anticoagulation therapy","critical, covid-2019, hypercoagulation status"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Heparin, Low-Molecular-Weight"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490474070017,"score":186.60956},{"pmid":32425264,"pmcid":"PMC7229939","title":"Severe arterial thrombosis associated with Covid-19 infection.","text":["Severe arterial thrombosis associated with Covid-19 infection.","*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia.","Thromb Res","Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick","32425264"],"abstract":["*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia."],"journal":"Thromb Res","authors":["Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425264","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.thromres.2020.05.025","keywords":["arterial thrombosis","covid-19","floating aortic thrombus","lower limb ischemia","sars-cov2 infection"],"locations":["thoracic"],"topics":["Case Report"],"weight":1,"_version_":1667252837779767296,"score":185.86023}]}